Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice

Treatment of heart failure with the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan improved glycemic control in individuals with type 2 diabetes. The relative contribution of neprilysin inhibition versus angiotensin II receptor antagonism to this glycemic benefit remains unknown. Thu...

Descripción completa

Detalles Bibliográficos
Autores principales: Esser, Nathalie, Schmidt, Christine, Barrow, Breanne M., Cronic, Laura, Hackney, Daryl J., Mongovin, Stephen M., Hogan, Meghan F., Templin, Andrew T., Castillo, Joseph J., Hull, Rebecca L., Zraika, Sakeneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207331/
https://www.ncbi.nlm.nih.gov/pubmed/35733766
http://dx.doi.org/10.3389/fendo.2022.888867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207331/
https://www.ncbi.nlm.nih.gov/pubmed/35733766
http://dx.doi.org/10.3389/fendo.2022.888867

Ejemplares similares